Antimicrobial resistance poses a significant threat to the sustainability of effective treatments
against the three most prevalent infectious diseases: malaria, human immunodeficiency …

Although caused by vastly different pathogens, the world's three most serious infectious
diseases, tuberculosis, malaria, and HIV-1 infection, share the common problem of drug …

Introduction: Currently, widely used antimalarial drugs have a limited clinical lifespan due to
parasite resistance development. With resistance continuously rising, antimalarial drug …

In the last century, advances in biomedical sciences led to improvements in quality of human
life mainly by decreasing the disease burden and providing various healthcare innovations …

Despite intensive research extending back to the 1930s, when the first synthetic antimalarial
drugs made their appearance, the repertoire of clinically licensed formulations remains very …

Anti-malarial chemotherapy based on a limited number of drugs has been the mainstay of
malaria control for many decades. However, the lack of new effective and affordable drugs …

Long before the discovery of drugs like 'antibiotic and anti-parasitic drugs', the infectious
diseases caused by pathogenic bacteria and parasites remain as one of the major causes of …

Antibiotics are the chemical or biochemical moieties that specifically and effectively inhibit
the growth of a pathogen but not the host organism and thus are employed in the treatment …

Background: Sir Alexander Fleming accidentally discovered antibiotics in 1928. Antibiotics
have played a significant role in treating infectious diseases. The extensive use of antibiotics …

Tuberculosis (TB) remains the most challenging infection to treat worldwide. The
contemporary TB regimens consist of 6–9 months of daily doses of four drugs in the existing …